How to camouflage a factory of 53,000 workers

"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."

HALO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,547,200.00

Halozyme Therapeutics Insider Trading History Chart

Halozyme Therapeutics Share Price & Price History

^$39.12

▲ +0.15 (0.38%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Halozyme Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/17/2024	Michael J. LaBarre	SVP	Sell	10,000	$38.49	$384,900.00	168,176
3/12/2024	Michael J. LaBarre	SVP	Sell	10,000	$41.64	$416,400.00	156,558
2/28/2024	Michael J. LaBarre	SVP	Sell	10,000	$39.55	$395,500.00	156,558
12/12/2023	Michael J. LaBarre	SVP	Sell	10,000	$39.63	$396,300.00	151,911
10/17/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.52	$365,200.00	151,911
9/19/2023	Michael J. LaBarre	SVP	Sell	10,000	$39.10	$391,000.00	151,911
8/31/2023	Helen Torley	CEO	Sell	10,000	$42.82	$428,200.00	623,666
8/29/2023	Helen Torley	CEO	Sell	10,000	$42.40	$424,000.00	623,666
8/22/2023	Michael J. LaBarre	SVP	Sell	10,000	$42.41	$424,100.00	151,911
8/22/2023	Michael J. LaBarre	SVP	Sell	10,000	$42.41	$424,100.00	151,911
8/17/2023	Helen Torley	CEO	Sell	10,000	$43.18	$431,800.00	623,666
8/14/2023	James M. Daly	Director	Sell	10,000	$43.74	$437,400.00	20,503
8/11/2023	James M. Daly	Director	Sell	10,000	$43.71	$437,100.00	30,503
7/26/2023	Helen Torley	CEO	Sell	10,000	$42.69	$426,900.00	623,666
7/18/2023	Michael J. LaBarre	SVP	Sell	10,000	$40.43	$404,300.00	141,911
6/21/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.00	$360,000.00	141,911
4/18/2023	Michael J. LaBarre	SVP	Sell	10,000	$36.00	$360,000.00	141,911
3/9/2023	Helen Torley	CEO	Sell	10,000	$42.73	$427,300.00	623,666
3/7/2023	Helen Torley	CEO	Sell	10,000	$45.47	$454,700.00	623,666
3/1/2023	Jeffrey William Henderson	Director	Sell	10,000	$47.71	$477,100.00	39,045
2/27/2023	Michael J. LaBarre	SVP	Sell	10,000	$49.55	$495,500.00	138,927
2/16/2023	Helen Torley	CEO	Sell	11,061	$49.26	$544,864.86	633,666
2/16/2023	Nicole Labrosse	CFO	Sell	2,525	$49.26	$124,381.50	9,066
2/15/2023	Michael J. LaBarre	SVP	Sell	10,000	$48.39	$483,900.00	143,477
2/8/2023	Helen Torley	CEO	Sell	10,000	$51.36	$513,600.00	587,177
1/19/2023	Helen Torley	CEO	Sell	10,000	$52.41	$524,100.00	587,177
1/17/2023	Michael J. LaBarre	SVP	Sell	10,000	$50.46	$504,600.00	143,137
12/15/2022	Helen Torley	CEO	Sell	10,000	$57.37	$573,700.00	587,177
12/13/2022	Michael J. LaBarre	SVP	Sell	10,000	$58.67	$586,700.00	153,137
12/5/2022	Matthew L. Posard	Director	Sell	10,000	$55.74	$557,400.00	115,189
12/2/2022	Matthew L. Posard	Director	Sell	10,000	$58.80	$588,000.00	125,189
11/17/2022	Helen Torley	CEO	Sell	10,000	$52.15	$521,500.00	587,177
11/15/2022	Michael J. LaBarre	SVP	Sell	10,000	$54.13	$541,300.00	163,137
11/15/2022	Nicole Labrosse	CFO	Sell	5,000	$53.81	$269,050.00	4,045
11/8/2021	Helen Torley	CEO	Sell	50,000	$39.82	$1,991,000.00
11/5/2021	Connie Matsui	Director	Sell	32,000	$40.38	$1,292,160.00
10/4/2021	Helen Torley	CEO	Sell	50,000	$40.09	$2,004,500.00
10/1/2021	Michael J. LaBarre	SVP	Sell	29,450	$39.93	$1,175,938.50
9/7/2021	Helen Torley	CEO	Sell	50,000	$42.38	$2,119,000.00	587,160
8/25/2021	Jean-Pierre Bizzari	Director	Sell	35,000	$41.01	$1,435,350.00
8/10/2021	Helen Torley	CEO	Sell	50,000	$41.11	$2,055,500.00
7/6/2021	Helen Torley	CEO	Sell	50,000	$45.97	$2,298,500.00	587,160
7/1/2021	Michael J. LaBarre	SVP	Sell	40,315	$45.70	$1,842,395.50
6/7/2021	Helen Torley	CEO	Sell	50,000	$39.66	$1,983,000.00	587,160
5/11/2021	Helen Torley	CEO	Sell	50,000	$43.02	$2,151,000.00	587,160

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

SEC Filings (Institutional Ownership Changes) for Halozyme Therapeutics (NASDAQ:HALO)

97.79% of Halozyme Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Halozyme Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	52,840	$2.15M	0.0%	-57.8%	0.042%
4/23/2024	Louisiana State Employees Retirement System	38,000	$1.55M	0.0%	+2.4%	0.030%
4/23/2024	Amalgamated Bank	69,163	$2.81M	0.0%	-16.4%	0.054%
4/23/2024	Nations Financial Group Inc. IA ADV	9,439	$0.38M	0.0%	+48.1%	0.007%
4/19/2024	AMI Asset Management Corp	137,390	$5.59M	0.3%	-4.0%	0.108%
4/19/2024	First Trust Direct Indexing L.P.	5,159	$0.21M	0.0%	-8.7%	0.004%
4/19/2024	Norden Group LLC	167,284	$6.81M	0.1%	+1,817.3%	0.132%
4/18/2024	State of Michigan Retirement System	32,438	$1.32M	0.0%	+2.2%	0.026%
4/18/2024	Allspring Global Investments Holdings LLC	696,127	$28.32M	0.0%	-4.4%	0.548%
4/16/2024	Hodges Capital Management Inc.	317,045	$12.90M	0.8%	+61.4%	0.250%
4/15/2024	Brookstone Capital Management	61,710	$2.51M	0.0%	+2.3%	0.049%
4/12/2024	FCF Advisors LLC	21,164	$0.86M	0.2%	+1.9%	0.017%
4/11/2024	Congress Asset Management Co. MA	407,867	$16.59M	0.1%	+16.2%	0.321%
4/10/2024	Park Avenue Securities LLC	8,294	$0.34M	0.0%	+17.3%	0.007%
4/9/2024	Rise Advisors LLC	611	$25K	0.0%	N/A	0.000%
4/5/2024	First Hawaiian Bank	5,041	$0.21M	0.0%	-63.6%	0.004%
4/5/2024	Juncture Wealth Strategies LLC	7,459	$0.30M	0.1%	N/A	0.006%
4/5/2024	Los Angeles Capital Management LLC	121,000	$4.92M	0.0%	+17.2%	0.095%
4/5/2024	CWM LLC	800	$33K	0.0%	-28.1%	0.001%
3/29/2024	Kapitalo Investimentos Ltda	3,593	$0.13M	0.0%	-61.0%	0.003%
3/22/2024	PNC Financial Services Group Inc.	11,364	$0.42M	0.0%	-4.2%	0.009%
3/21/2024	Healthcare of Ontario Pension Plan Trust Fund	105,000	$3.88M	0.0%	N/A	0.083%
3/11/2024	Vanguard Group Inc.	13,259,514	$490.07M	0.0%	+1.2%	10.436%
3/5/2024	Fisher Asset Management LLC	276,902	$10.23M	0.0%	+0.6%	0.218%
3/5/2024	Wellington Management Group LLP	180,856	$6.68M	0.0%	+16.1%	0.143%
3/4/2024	Congress Asset Management Co. MA	351,076	$12.98M	0.1%	+15.6%	0.277%
3/1/2024	Goldman Sachs Group Inc.	1,541,610	$56.98M	0.0%	-11.0%	1.216%
2/28/2024	American International Group Inc.	241,898	$8.94M	0.0%	-3.1%	0.191%
2/26/2024	Virtu Financial LLC	16,421	$0.61M	0.0%	N/A	0.013%
2/26/2024	Teachers Retirement System of The State of Kentucky	44,021	$1.63M	0.0%	-4.6%	0.035%
2/26/2024	Neo Ivy Capital Management	5,602	$0.21M	0.5%	N/A	0.004%
2/20/2024	Aurora Investment Counsel	37,156	$1.37M	0.8%	+5.4%	0.028%
2/15/2024	Penn Capital Management Company LLC	279,540	$10.37M	1.0%	-13.9%	0.212%
2/14/2024	First Light Asset Management LLC	134,050	$4.95M	0.4%	-57.2%	0.101%
2/14/2024	Future Fund LLC	7,166	$0.27M	0.7%	-16.3%	0.005%
2/14/2024	Scout Investments Inc.	261,483	$9.66M	0.2%	-1.5%	0.198%
2/14/2024	Sectoral Asset Management Inc.	6,030	$0.22M	0.1%	-95.9%	0.005%
2/14/2024	Prudential PLC	33,773	$1.25M	0.0%	N/A	0.026%
2/13/2024	Epoch Investment Partners Inc.	1,163,033	$42.99M	0.2%	+250.5%	0.880%
2/13/2024	American International Group Inc.	241,898	$8.94M	0.1%	-3.1%	0.183%
2/13/2024	Stephens Investment Management Group LLC	1,518,455	$56.12M	0.8%	+4.4%	1.149%
2/13/2024	Rafferty Asset Management LLC	224,724	$8.31M	0.0%	-2.8%	0.170%
2/13/2024	Campbell & CO Investment Adviser LLC	17,369	$0.64M	0.1%	+12.3%	0.013%
2/12/2024	Eagle Asset Management Inc.	232,113	$8.58M	0.0%	-59.6%	0.176%
2/12/2024	Evoke Wealth LLC	36,657	$1.36M	0.0%	N/A	0.028%
2/12/2024	TD Asset Management Inc	1,983,916	$73.33M	0.1%	+517.0%	1.502%
2/12/2024	United Services Automobile Association	10,057	$0.37M	0.0%	N/A	0.008%
2/12/2024	Bernzott Capital Advisors	124,979	$4.62M	1.8%	-27.3%	0.095%
2/12/2024	Artisan Partners Limited Partnership	6,689,058	$247.23M	0.4%	-13.3%	5.064%
2/12/2024	Hsbc Holdings PLC	100,101	$3.70M	0.0%	+27.7%	0.076%
2/9/2024	Nations Financial Group Inc. IA ADV	6,372	$0.24M	0.0%	N/A	0.005%
2/9/2024	Congress Wealth Management LLC DE	52,511	$1.94M	0.0%	+8.2%	0.040%
2/9/2024	Hoylecohen LLC	8,775	$0.32M	0.0%	+8.3%	0.007%
2/9/2024	Orion Portfolio Solutions LLC	29,725	$1.06M	0.0%	-15.9%	0.023%
2/9/2024	Commerce Bank	14,660	$0.54M	0.0%	-3.2%	0.011%
2/9/2024	Ontario Teachers Pension Plan Board	34,346	$1.27M	0.0%	+137.5%	0.026%
2/9/2024	Affinity Investment Advisors LLC	8,886	$0.33M	0.2%	-43.4%	0.007%
2/9/2024	Aigen Investment Management LP	8,942	$0.33M	0.1%	+35.9%	0.007%
2/9/2024	Assetmark Inc.	105,192	$3.89M	0.0%	+71.1%	0.080%
2/9/2024	GW&K Investment Management LLC	2,226,538	$82.29M	0.8%	-5.0%	1.685%
2/9/2024	Quest Partners LLC	11,789	$0.44M	0.1%	N/A	0.009%
2/9/2024	Trexquant Investment LP	119,584	$4.42M	0.1%	+4.3%	0.091%
2/9/2024	Corient Private Wealth LLC	21,881	$0.81M	0.0%	+17.2%	0.017%
2/9/2024	Coldstream Capital Management Inc.	6,921	$0.26M	0.0%	N/A	0.005%
2/9/2024	PNC Financial Services Group Inc.	11,364	$0.42M	0.0%	-4.2%	0.009%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	126,635	$4.68M	0.1%	N/A	0.096%
2/9/2024	Dynamic Technology Lab Private Ltd	23,402	$0.87M	0.1%	-19.8%	0.018%
2/9/2024	Norges Bank	1,215,769	$44.94M	0.0%	N/A	0.920%
2/8/2024	Mizuho Markets Americas LLC	446,661	$16.51M	0.5%	+10.9%	0.338%
2/8/2024	Verity Asset Management Inc.	28,628	$1.06M	0.7%	-8.6%	0.022%
2/8/2024	Wafra Inc.	53,877	$1.99M	0.1%	+79.2%	0.041%
2/8/2024	Great Lakes Advisors LLC	104,005	$3.84M	0.0%	-34.8%	0.079%
2/8/2024	EFG Asset Management North America Corp.	130,732	$4.83M	0.9%	-5.1%	0.099%
2/8/2024	Quadrant Capital Group LLC	3,414	$0.13M	0.0%	+22.4%	0.003%
2/8/2024	Torray Investment Partners LLC	39,886	$1.47M	0.2%	+53.4%	0.030%
2/8/2024	Janney Montgomery Scott LLC	12,788	$0.47M	0.0%	N/A	0.010%
2/8/2024	Vanguard Personalized Indexing Management LLC	20,050	$0.74M	0.0%	+86.0%	0.015%
2/7/2024	Boston Partners	552,392	$20.22M	0.0%	+562.2%	0.418%
2/7/2024	Principal Financial Group Inc.	560,808	$20.73M	0.0%	-5.1%	0.425%
2/7/2024	Envestnet Portfolio Solutions Inc.	11,083	$0.41M	0.0%	-11.2%	0.008%
2/7/2024	Dimensional Fund Advisors LP	1,613,113	$59.62M	0.0%	+9.9%	1.221%
2/7/2024	Teacher Retirement System of Texas	30,535	$1.13M	0.0%	-19.0%	0.023%
2/7/2024	Mesirow Institutional Investment Management Inc.	453,827	$16.77M	1.6%	+19.3%	0.344%
2/7/2024	Principal Securities Inc.	920	$34K	0.0%	N/A	0.001%
2/6/2024	Charles Schwab Investment Management Inc.	1,736,122	$64.17M	0.0%	+2.2%	1.314%
2/6/2024	Private Advisor Group LLC	23,451	$0.87M	0.0%	+6.2%	0.018%
2/6/2024	Gallacher Capital Management LLC	11,403	$0.42M	0.2%	+85.2%	0.009%
2/6/2024	Ifrah Financial Services Inc.	6,060	$0.22M	0.1%	-5.8%	0.005%
2/6/2024	LSV Asset Management	462,400	$17.09M	0.0%	N/A	0.350%
2/6/2024	M&T Bank Corp	96,322	$3.56M	0.0%	+0.9%	0.073%
2/6/2024	Amalgamated Bank	82,759	$3.06M	0.0%	-1.2%	0.063%
2/6/2024	Doheny Asset Management CA	22,578	$0.83M	0.8%	-6.6%	0.017%
2/6/2024	Los Angeles Capital Management LLC	103,284	$3.82M	0.0%	+2.0%	0.078%
2/6/2024	Natixis Advisors L.P.	38,324	$1.42M	0.0%	-14.5%	0.029%
2/6/2024	First Horizon Advisors Inc.	1,491	$55K	0.0%	+24.5%	0.001%
2/6/2024	Swiss National Bank	260,000	$9.61M	0.0%	-10.2%	0.197%
2/6/2024	Fisher Asset Management LLC	276,822	$10.23M	0.0%	+0.6%	0.210%
2/6/2024	First Trust Direct Indexing L.P.	5,653	$0.21M	0.0%	N/A	0.004%
2/5/2024	Norden Group LLC	8,725	$0.32M	0.1%	+54.8%	0.007%
2/5/2024	Kestra Private Wealth Services LLC	11,199	$0.41M	0.0%	N/A	0.008%

Data available starting January 2016

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Today's Range

Now: $39.12

$38.89

$39.69

50 Day Range

MA: $39.71

$35.06

$41.95

52 Week Range

Now: $39.12

$29.85

$45.00

Volume

620,516 shs

Average Volume

837,789 shs

Market Capitalization

$4.97 billion

P/E Ratio

18.54

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Halozyme Therapeutics?: Halozyme Therapeutics' top insider shareholders include:
Helen Torley (CEO)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Jeffrey William Henderson (Director)
James M Daly (Director)
Nicole Labrosse (CFO)
Learn More about top insider investors at Halozyme Therapeutics.
Who are the major institutional investors of Halozyme Therapeutics?: Halozyme Therapeutics' top institutional investors include:
Allspring Global Investments Holdings LLC — 0.55%
Congress Asset Management Co. MA — 0.32%
Hodges Capital Management Inc. — 0.25%
Norden Group LLC — 0.13%
AMI Asset Management Corp — 0.11%
Los Angeles Capital Management LLC — 0.10%
Learn More about top institutional investors of Halozyme Therapeutics stock.
Which major investors are selling Halozyme Therapeutics stock?: Within the last quarter, HALO stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Allspring Global Investments Holdings LLC
Amalgamated Bank
First Hawaiian Bank
AMI Asset Management Corp
First Trust Direct Indexing L.P.
CWM LLC
In the last year, company insiders that have sold Halozyme Therapeutics company stock include:
Helen Torley (CEO)
Michael J Labarre (SVP)
Matthew L Posard (Director)
Learn More investors selling Halozyme Therapeutics stock.
Which major investors are buying Halozyme Therapeutics stock?: Within the last quarter, HALO stock was acquired by institutional investors including:
Norden Group LLC
Hodges Capital Management Inc.
Congress Asset Management Co. MA
Los Angeles Capital Management LLC
Juncture Wealth Strategies LLC
Nations Financial Group Inc. IA ADV
Brookstone Capital Management
Park Avenue Securities LLC